DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20210748

Survey on common practice in management of preeclampsia by obstetricians

Komal Chavan, Niranjan Chavan, Hitendrasing D. Rajput, Hera Mirza, Sneha Venkateswaran, Shalini Mahapatra

Abstract


Background: Approximately 72,000 pregnant women all over the world die every year due to direct or indirect complications related to eclampsia and severe preeclampsia. Incidence of hypertensive disorders in pregnancy in India is found to be 10.08% as per the data collected by the National Eclampsia Registry (NER). Here we present the results of a survey conducted among obstetricians in India to know the common practices in the management of pre-eclampsia followed in our country.

Methods: Observational study of survey which was conducted for the period of 1 month from 22nd May 2020 to 22nd June 2020. Questionnaire was prepared on surveyheart.com and sent to obstetricians via Social media platforms to the members of FOGSI. all answers 'collected' and results were prepared from given answers. The survey was answered online by 289 obstetricians.

Results: For mild to moderate pre-eclampsia Labetalol is still first line antihypertensive agent being used by many of the obstetricians. In our study also we found out Tab Labetalol 100mg BD is the most preferred type (278, 96.19%) of first line anti-hypertensive in cases of pre-eclampsia followed by Cap Nifedipine 5mg QID and Tab Amlodipine 5mg OD respectively.

Conclusions: Comprehensive educational efforts and skill building modules are need of hour to keep every practicing obstetrician regarding recent advances in standard practice protocols.With close monitoring of all cases and well selected anti-hypertensive treatment, it is possible to achieve favourable outcomes for the mother and the baby.


Keywords


Aspirin, Fundoscopy, IUGR, Labetalol, Pre-eclampsia

Full Text:

PDF

References


Peres G, Mariana M, Cairrão E. Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal. J Cardiovasc Dev Dis. 2018;5(1):3.

NICE. Hypertension in pregnancy: diagnosis and management (NG133). NICE Guidel. 2020;(June 2019):55.

Gupte S, Wagh G. Preeclampsia-eclampsia. J Obstet Gynecol India. 2014;64(1):4–13.

Hypertension in pregnancy : the management of hypertensive disorders during pregnancy Hypertension in pregnancy the management of hypertensive disorders. 2019;(June).

5. Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(2):133–7.

RCOG. Information for you. R Coll Obstet Gynaecol patient Inf Pre-eclampsia. 2012;20(August 2012):1–7. Available from: tps://www.rcog.org.uk/globalassets/documents/patients/patient-information-leaflets/pregnancy/pi-pre-eclampsia.pdf.

Sammour MB, El-Kabarity H, Fawzy MM, Schindler a. E. Prevention and treatment of pre-eclampsia and eclampsia. J Steroid Biochem Mole Biol. 2011;97:439–40.

Shennan A, Duhig K, Vandermolen B. Recent advances in the diagnosis and management of pre-eclampsia. F1000Research. 2018;7:1–8.